M1 receptors play a central role in modulating AD-like pathology in transgenic mice

Neuron

Volumn 49, Issue 5, 2006, Pages 671-682

  Caccamo, Antonella ^a   Oddo, Salvatore ^a   Billings, Lauren M ^a   Green, Kim N ^a   Martinez Coria, Hilda ^a   Fisher, Abraham ^b   LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 8 METHYL 1 THIA 4,8 DIAZASPIRO[4.5]DECAN 3 ONE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DICYCLOVERINE; GLYCOGEN SYNTHASE KINASE 3BETA; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M1 RECEPTOR ANTAGONIST; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONDITIONING; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEAR; HIPPOCAMPUS; MOLECULAR MECHANICS; MOLECULAR WEIGHT; MOUSE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD147; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN; CELL COUNT; CYTOSKELETAL PROTEINS; DICYCLOMINE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCAPE REACTION; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MUSCARINIC ANTAGONISTS; NUCLEAR PROTEINS; PIPERIDINES; PROTEIN KINASE C; REACTION TIME; RECEPTOR, MUSCARINIC M1; SPATIAL BEHAVIOR; SPIRO COMPOUNDS; TAU PROTEINS; THIAZOLES; TIME FACTORS;

EID: 33344458827     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2006.01.020     Document Type: Article

References (44)

1. T.M. Allinson, E.T. Parkin, A.J. Turner, and N.M. Hooper ADAMs family members as amyloid precursor protein alpha-secretases J. Neurosci. Res. 74 2003 342 352
2. V. Bigl, and S. Rossner Amyloid precursor protein processing in vivo-insights from a chemically-induced constitutive overactivation of protein kinase C in Guinea pig brain Curr. Med. Chem. 10 2003 871 882
3. L.M. Billings, S. Oddo, K.N. Green, J.L. McGaugh, and F.M. Laferla Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice Neuron 45 2005 675 688
4. J.D. Buxbaum, M. Oishi, H.I. Chen, R. Pinkas-Kramarski, E.A. Jaffe, S.E. Gandy, and P. Greengard Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor Proc. Natl. Acad. Sci. USA 89 1992 10075 10078
5. J.D. Buxbaum, K.N. Liu, Y. Luo, J.L. Slack, K.L. Stocking, J.J. Peschon, R.S. Johnson, B.J. Castner, D.P. Cerretti, and R.A. Black Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor J. Biol. Chem. 273 1998 27765 27767
6. M.P. Cuajungco, K.Y. Faget, X. Huang, R.E. Tanzi, and A.I. Bush Metal chelation as a potential therapy for Alzheimer's disease Ann. N Y Acad. Sci. 920 2000 292 304
7. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
8. R.B. DeMattos, K.R. Bales, D.J. Cummins, J.C. Dodart, S.M. Paul, and D.M. Holtzman Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 98 2001 8850 8855
9. R.M. Eglen, A. Choppin, and N. Watson Therapeutic opportunities from muscarinic receptor research Trends Pharmacol. Sci. 22 2001 409 414
10. O.V. Forlenza, J.M. Spink, R. Dayanandan, B.H. Anderton, O.F. Olesen, and S. Lovestone Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons J. Neural Transm. 107 2000 1201 1212
11. A. Giachetti, E. Giraldo, H. Ladinsky, and E. Montagna Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine Br. J. Pharmacol. 89 1986 83 90
12. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
13. R. Haring, A. Fisher, D. Marciano, Z. Pittel, Y. Kloog, A. Zuckerman, N. Eshhar, and E. Heldman Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion J. Neurochem. 71 1998 2094 2103
14. B. Ibach, and E. Haen Acetylcholinesterase inhibition in Alzheimer's Disease Curr. Pharm. Des. 10 2004 231 251
15. J.L. Jankowsky, A. Savonenko, G. Schilling, J. Wang, G. Xu, and D.R. Borchelt Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development Curr. Neurol. Neurosci. Rep. 2 2002 457 464
16. C. Janus, A.L. Phinney, M.A. Chishti, and D. Westaway New developments in animal models of Alzheimer's disease Curr. Neurol. Neurosci. Rep. 1 2001 451 457
17. I. Karkkainen, E. Rybnikova, M. Pelto-Huikko, and A.P. Huovila Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS Mol. Cell. Neurosci. 15 2000 547 560
18. M. Kitazawa, S. Oddo, T.R. Yamasaki, K.N. Green, and F.M. LaFerla Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease J. Neurosci. 25 2005 8843 8853
19. S. Lammich, E. Kojro, R. Postina, S. Gilbert, R. Pfeiffer, M. Jasionowski, C. Haass, and F. Fahrenholz Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease Proc. Natl. Acad. Sci. USA 96 1999 3922 3927
20. A.I. Levey, C.A. Kitt, W.F. Simonds, D.L. Price, and M.R. Brann Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies J. Neurosci. 11 1991 3218 3226
21. J.L. McGaugh, C.K. McIntyre, and A.E. Power Amygdala modulation of memory consolidation: interaction with other brain systems Neurobiol. Learn. Mem. 78 2002 539 552
22. J.L. Muir Acetylcholine, aging, and Alzheimer's disease Pharmacol. Biochem. Behav. 56 1997 687 696
23. R.M. Nitsch, B.E. Slack, R.J. Wurtman, and J.H. Growdon Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors Science 258 1992 304 307
24. R.M. Nitsch, B.E. Slack, S.A. Farber, P.R. Borghesani, J.G. Schulz, C. Kim, C.C. Felder, J.H. Growdon, and R.J. Wurtman Receptor-coupled amyloid precursor protein processing Ann. N Y Acad. Sci. 695 1993 122 127
25. A. Nordberg, and B. Winblad Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains Neurosci. Lett. 72 1986 115 119
26. A. Nordberg, I. Alafuzoff, and B. Winblad Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia J. Neurosci. Res. 31 1992 103 111
27. A. Nordberg, E. Hellstrom-Lindahl, M. Lee, M. Johnson, M. Mousavi, R. Hall, E. Perry, I. Bednar, and J. Court Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 2002 655 658
28. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 39 2003 409 421
29. S. Oddo, L. Billings, J.P. Kesslak, D.H. Cribbs, and F.M. LaFerla Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome Neuron 43 2004 321 332
30. S. Oddo, A. Caccamo, K.N. Green, K. Liang, L. Tran, Y. Chen, F.M. Leslie, and F.M. LaFerla Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 102 2005 3046 3051
31. I. Pinnix, U. Musunuru, H. Tun, A. Sridharan, T. Golde, C. Eckman, C. Ziani-Cherif, L. Onstead, and K. Sambamurti A novel gamma-secretase assay based on detection of the putative C-terminal fragment-gamma of amyloid beta protein precursor J. Biol. Chem. 276 2001 481 487
32. R. Postina, A. Schroeder, I. Dewachter, J. Bohl, U. Schmitt, E. Kojro, C. Prinzen, K. Endres, C. Hiemke, and M. Blessing A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model J. Clin. Invest. 113 2004 1456 1464
33. P. Riekkinen Jr., B.H. Schmidt, and F.J. van der Staay Animal models in the development of symptomatic and preventive drug therapies for Alzheimer's disease Ann. Med. 30 1998 566 576
34. K. Rosenblum, M. Futter, M. Jones, E.C. Hulme, and T.V. Bliss ERKI/II regulation by the muscarinic acetylcholine receptors in neurons J. Neurosci. 20 2000 977 985
35. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, and K. Khan Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
36. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
37. D.M. Skovronsky, S. Fath, V.M. Lee, and M.E. Milla Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques J. Neurobiol. 49 2001 40 46
38. D.G. Spencer Jr., E. Horvath, and J. Traber Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections Brain Res. 380 1986 59 68
39. K. Sugaya, E. Giacobini, and V.A. Chiappinelli Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease J. Neurosci. Res. 27 1990 349 359
40. P.H. Sugden, and A. Clerk Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors Cell. Signal. 9 1997 337 351
41. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, and R. Loeloff Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
42. J. Wei, E.A. Walton, A. Milici, and J.J. Buccafusco m1-m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC J. Neurochem. 63 1994 815 821
43. P.J. Whitehouse, A.M. Martino, P.G. Antuono, P.R. Lowenstein, J.T. Coyle, D.L. Price, and K.J. Kellar Nicotinic acetylcholine binding sites in Alzheimer's disease Brain Res. 371 1986 146 151
44. N.J. Woolf The critical role of cholinergic basal forebrain neurons in morphological change and memory encoding: a hypothesis Neurobiol. Learn. Mem. 66 1996 258 266